Article Information
PubMed
Print ISSN
Online ISSN
History
- Accepted April 7, 2009
- Received January 13, 2009
- Published online June 18, 2009.
Article Versions
- Earlier version (April 9, 2009 - 08:52).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Scott W. Grimm,
- Heidi J. Einolf,
- Steven D. Hall,
- Kan He,
- Heng-Keang Lim,
- Kah-Hiing John Ling,
- Chuang Lu,
- Amin A. Nomeir,
- Eleanore Seibert,
- Konstantine W. Skordos,
- George R. Tonn,
- Robert Van Horn,
- Regina W. Wang,
- Y. Nancy Wong,
- Tian J. Yang and
- R. Scott Obach
- AstraZeneca Pharmaceuticals, Wilmington, Delaware (S.W.G.); Allergan Inc., Irvine, California (K.-H.J.L.); Amgen Inc., South San Francisco, California (G.R.T.); Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut (E.S.); Bristol-Myers Squibb Co., Princeton, New Jersey (K.H.); Eisai Research Institute, Andover, Massachusetts (Y.N.W.); Eli Lilly and Company, Indianapolis, Indiana (S.D.H.); GlaxoSmithKline, King of Prussia, Pennsylvania (K.W.S.); Hoffmann-La Roche, Nutley, New Jersey (T.J.Y.); Johnson & Johnson Pharmaceutical Research Institute, Raritan, New Jersey (H.-K.L.); Merck Research Laboratories, Rahway, New Jersey (R.W.W.); Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts (C.L.); Novartis Pharmaceuticals Corporation, East Hanover, New Jersey (H.J.E.); Pfizer Inc., Groton, Connecticut (R.S.O.); Sanofi-Aventis, Malvern, Pennsylvania (R.V.H.); and Schering-Plough Research Institute, Kenilworth, New Jersey (A.A.N.)
- Address correspondence to:
R. Scott Obach, Pfizer Inc., Groton, CT 06340. E-mail: r.scott.obach{at}pfizer.com
Statistics from Altmetric.com
Article usage
In this issue
The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America
